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Introduction: Repair of contaminated abdominal wall defect in a geriatric patient is a challenge for the surgeon. We
present the case of the oldest patient (105-years old) to successfully undergo a single-stage repair of a contaminated
abdominal wall defect with a Permacol™ implant.
Case presentation: A 105-year-old Caucasian woman presented to our emergency room with a clinical and
radiological diagnosis of small bowel obstruction due to prior operative adhesions. She underwent laparotomy
with small bowel resection and primary closure of her abdomen. There was total eventration of her bowel through
the suture line 9 days after surgery. She underwent a second laparotomy that revealed no signs of peritonitis or
turbid fluid. Her abdomen was closed with a 15×10cm Permacol™ implant sutured sublay with prolene sutures.
Her postoperative period was unremarkable. After a follow-up period of 3 years and 2 months, there was no sign
of recurrent hernia or wound contamination.
Conclusion: We suggest that Permacol™ mesh can be considered an efficient alternative to primary closure or
synthetic mesh in geriatric patients with contaminated abdominal wall defects.
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The reconstruction of an abdominal wall defect or the
repair of a large ventral hernia is a challenge for sur-
geons. In the repair of clean ventral hernia, the use of
synthetic mesh can lead to a 50% reduction in hernia
recurrence [1]. However, the use of synthetic mesh in
cases of contamination is associated with serious compli-
cations such as fistula formation, adhesions, skin erosion
and increased susceptibility to infections [2]. Thus, their
use in contaminated fields is associated with high rates
of morbidity and is strongly discouraged [3,4]. As a
result, some advocate dividing definitive hernia repair
into a two-stage approach [5,6]. The first operation
entails removal of the infectious source, and then the
patient must wait for 6 to 12 months before the second,* Correspondence: iditm@barzi.health.gov.il
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unless otherwise stated.definitive repair operation. For geriatric patients, how-
ever, this multistage method is especially problematic as
most of them have numerous comorbidities. An opera-
tive protocol comprising two stages separated by an
interval of at least 6 months aggravates the risks to geri-
atric patients for increased postoperative complications.
Recently, the treatment focus has shifted to biopros-
thetic meshes that provide strength and that promote
host tissue incorporation and infection resistance, which
together make them especially suited to treatment in
contaminated fields when using a single-stage approach.
Permacol™ contains non-reconstructed porcine dermal
collagen that has been stabilized against degradation
by collagenase while retaining its elastin content and
flexibility [7]. Recent case series have reported that
Permacol™ is feasible and safe with the potential to be an
acceptable alternative to prosthetic mesh in the repair of
complicated and contaminated abdominal wall defectsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mesh in the reconstruction of the abdominal wall of a
105-year-old patient with a 3-year follow up. To the best
of our knowledge, this case is the oldest documented
patient to undergo abdominal wall reconstruction with
Permacol™ mesh.
Case presentation
A 105-year-old Caucasian woman was admitted to our
department complaining of diffuse abdominal pain with
recurrent vomiting for a day. Her past surgical history
included the repair of an incarcerated umbilical hernia 3
weeks prior and an open cholecystectomy 13 years
before. Her past medical history included ischemic heart
disease, atrial fibrillation with a cardiac pacemaker and
hypertension. Despite her age, she was clear-minded,
and she managed to fulfill her daily activities in her own
home with the help of a nursing assistant. On physical
examination her abdomen was distended and tympanic
with tenderness in the postoperative scar near her
umbilicus. A computed tomography of her abdomen
demonstrated small bowel obstruction. A midline lapar-
otomy through the previous scar revealed numerous
adhesions of the small bowel. During adhesiolysis, one
small bowel loop was opened and a resection with pri-
mary anastomosis was created. Her abdominal fascia
was closed with polydioxanone loop and her skin was
closed with tension nylon sutures.
There was a total eventration of her bowel through
the suture line 9 days after surgery. She underwent a
second laparotomy that revealed necrosis in the fascia
edges. No signs of peritonitis or turbid fluid in periton-
eal lavage were observed. Due to the fascial necrosis the
field was believed to be contaminated. As a result, fascial
edges were resected and instead of using a regular syn-
thetic mesh, we decided to close her abdomen with a
15×10cm Permacol™ implant (Covidien) sutured sublay
with prolene sutures. Her abdominal skin was closed
with several single nylon sutures, leaving an interval of a
few centimeters between one suture and the next, due to
contamination. After the second surgery, the postopera-
tive period was devoid of complications. As part of the
conservative treatment approach, she was gradually
returned to oral nutrition that was accompanied by nor-
mal bowel movements. Her abdominal skin was closed
with close nylon sutures 7 days after the second surgery,
and she reported feeling well, with no fever. Her abdo-
men was soft and non-tender without any signs of surgi-
cal site infection. Discharged later that day, she returned
to her house as clear-minded and functional as she was
prior to her admission to hospital.
During a follow-up period of 3 years and 2 months,
there was no sign of either recurrent hernia or wound
contamination. The patient reported that she felt good,and she had no complaints of abdominal pain. She died,
3.5 years after surgery, at the age of 108 of cardiac arrest
unrelated to the abdominal surgery. For clarification,
since the report is retrospective and obviously we cannot
call the patient for a follow-up examination, all the data
for the follow-up was collected from medical records, as
the patient was hospitalized several times due to other
reasons, not related to the surgery, and underwent phys-
ical examination by a doctor.
Discussion
Permacol™ is a porcine-derived acellular dermal sheet
composed predominantly of type I collagen (93 to
95%). During the manufacturing process the cellular
components are removed and the collagen of the
dermis is treated with hexamethylene diisocyanate
(HMDI) to increase the degree of cross-linking [9]. The
HMDI treatment also promotes neovascularization
and tissue ingrowth, thereby creating an environment
that favors antibiotic permeation [10,11]. In addition,
due to its smooth surface and a lack of foreign body
reaction when implanted, Permacol™ mesh can be
placed equally well in contact with the bowel and with
adipose tissue.
The use of Permacol™ in hernia repair was first pro-
posed in 1984 [12]. Subsequent in vivo studies evaluating
the different biologic meshes reported that Permacol™ is
a safe prosthetic material for ventral hernia repair,
supporting hernia healing by strengthening the damaged
tissue [13,14]. Catena et al. [8] reported a case series of
seven patients, age range of 69 to 83, who were treated
with Permacol™ for complicated incisional hernias. In a
mean follow-up of 11.1 months no recurrence or wound
infection was observed. Another study [15] reported a
case series of 28 patients ranging in age from 44 to 83
with acute and chronic abdominal wall defects, environ-
ments with potentially contaminated wounds, treated
with Permacol™ mesh. They described three recurrences
(15%) in a median follow-up of 16 months. Likewise,
Loganathan et al. [7] reported the cases of 15 patients,
age range 36 to 76, who underwent repair of complex or
recurrent hernia with Permacol™, some of the patients
had infected surgical fields. Two recurrences were re-
ported, one in a parastomal hernia within 30 days, most
likely due to surgical technique, and the other in an inci-
sional hernia. Although not clearly stated in the paper,
the latter case was probably a late recurrence.
In spite of such promising results, the use of Perma-
col™ in contaminated surgical fields is still controversial.
In fact, recent reports have cast doubt on those results.
García-Pumarino et al. [16] reported a comparative
in vitro and in vivo study of collagen meshes (Collamend®,
Surgisis® and Permacol™®) to the polytetrafluoroethylene
mesh, Preclude®, in contaminated surgical fields. They
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any bacterial adhesion or bacterial clearance benefits. In
addition, Rosen et al. [17] reported a large study of 128
patients, mean age 58.2±13.5 years, evaluating the long-
term results after repairing contaminated abdominal
wall defects with biologic meshes. Although the biologic
meshes that were tested (Strattice™, AlloDerm®, Biode-
sign, XenMatrix™ and BioA) did not include Permacol™,
and in our case the use of Permacol™ with a follow up of
approximately 3 years revealed no signs of hernia recur-
rence, this finding still raises the question of the long-
term efficacy of Permacol™. For clarification, recently
studies report favorable outcomes with synthetic mesh
in a contaminated ventral hernia [18]. However, their
usage in a contaminated field is not yet a standard of
care, and due to this controversial issue the use of
a biological mesh is still a reasonable and effective
technique.
While the general issue of abdominal wall repair in
the presence of contamination is controversial, it be-
comes even more complicated for geriatric patients,
who often have multiple comorbidities. This situation
precludes the use of a two-stage surgical procedure
with geriatric patients, in whom the potential increase
in operative risk is unacceptable. Moreover, the high
rates of pulmonary diseases in these patients rule out
the use of a direct suture, which will increase intra-
abdominal pressure, thereby influencing respiratory
dynamics [19].
Based on the literature reviewed here, we decided in
our case of a 105-year-old patient with bowel eventra-
tion to repair her abdominal wall defect with Permacol™
mesh. Over the course of a follow-up period of 3 years
and 2 months, we did not observe any sign of recurrent
hernia or long-term infectious complications. In addition
to the surgical technique of using a biological mesh, we
must mention that it was a combination of better peri-
operative care and preoperative preparation (especially
in a geriatric patient) that were the basis of the success-
ful treatment.Conclusions
The repair of a contaminated abdominal wall defect in a
geriatric patient is a challenge for the surgeon. Due to
their high cost and the fear of postoperative complica-
tions, many surgeons decide not to use a biological mesh
in a geriatric patient. We present the case of the oldest,
to the best of our knowledge, patient (105-years old) to
have successfully undergone a single-stage repair using
a Permacol™ implant. We suggest that Permacol™ mesh
can be considered an efficient alternative to primary
closure or synthetic mesh in geriatric patients with con-
taminated abdominal wall defects.Consent
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